
CFTR MUTATIONS IN NORTHERN GREECE.
HIGH FREQUENCY OF MUTATION 621+1 (G->T)
Kalogeridis A1,2, Kouvatsi A1, Tsanakas I2 *Corresponding Author: Dr. Anastasia Kouvatsi, Department of Genetics, Development and Molecular Biology, School of Biology, Aristotle University of Thessaloniki, 54006 Thessaloniki, Greece; Tel: +30310- 998361;
Fax: +30310-998374; E-mail: akouvats@bio.auth.gr
page: 11
|
RESULTS
In this study, 132 CF chromosomes were analyzed for 11 common mutations (Table 1). These mutations account for 80.1% of the CF alleles in patients from northern Greece. The DF508 has a frequency of 56.06%, while the second most frequent mutation is the 621+1 (G®T) with 12.12%.
The genotype frequencies among the 66 CF patients are shown in Table 1. The most frequent genotypes are the DF508/DF508, the DF508/unknown, and the DF508/621+1 (G®T). All the other genotypes show frequencies lower than 10%.
The distribution of the CF genotypes according to the patient's exact region of origin shows the following: the most frequent genotypes in the region of Macedonia are the DF508/DF508 and DF508/unknown with equal frequency (24.4%), followed by the DF508/621+1 (G®T) (15.5%). In the region of Thessaly the most frequent genotype is the DF508/DF508 (41.17%), followed by the DF508/621+1 (G®T) (23.3%) and DF508/unknown (17.64%).
The haplotypes for Xv-2c, KM.19, MET-D, MET-H and M470V DNA polymorphic markers, in non-CF chromosomes and CF chromosomes of patients carrying the 621+1 (G®T) mutation are given in Table 2. This analysis revealed that almost all of the 621+1 (G®T) chromosomes are associated with the H5 haplotype. On the other hand, the DF508 chromosomes are mainly in association with haplotype H3. It seems that the 621+1 (G®T) chromosomes found in northern Greece are associated with a haplotype that is not detected in DF508 or in the non-CF chromosomes.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|